Publications by authors named "Alison Fitzgerald"

Claim this Profile
B
Bullseye: precision in laparoscopic isthmocele repair with the "Taurus T method".
Jeremy Applebaum, Alison C Fitzgerald, Golnaz Namazi

Fertil Steril· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation effectiveness of an antenatal lifestyle intervention to optimize gestational weight gain in women with obesity.
Rebecca F Goldstein, Jacqueline A Boyle, Shamil D Cooray, Anju E Joham, Alison L Fitz-Gerald

Obesity (Silver Spring)· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of a 40-Gene Expression Profile With Risk of Metastatic Disease Progression of Cutaneous Squamous Cell Carcinoma and Specification of Benefit of Adjuvant Radiation Therapy.
Sarah T Arron, Javier Cañueto, Jennifer Siegel, Alison Fitzgerald, Anesh Prasai

Int J Radiat Oncol Biol Phys· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating the 40-Gene Expression Profile (40-GEP) Test Improves Metastatic Risk-Stratification Within Clinically Relevant Subgroups of High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients.
Ashley Wysong, Ally-Khan Somani, Sherrif F Ibrahim, Javier Cañueto, Alison L Fitzgerald

Dermatol Ther (Heidelb)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of induction of labor at 39 weeks vs expectant management by cervical examination.
Alison C Fitzgerald, Anjali J Kaimal, Sarah E Little

Am J Obstet Gynecol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolving best practices in the surgical management of endometriosis - examining the evidence and expert opinion.
Elisa Jorgensen, Alison Fitzgerald, Nisse Clark

Curr Opin Obstet Gynecol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diabetes Mellitus Type 1 Presenting in the Setting of Diabetic Ketoacidosis and Acute SARS-CoV-2 Infection in Pregnancy.
George A Stamatiades, Francesca Galbiati, Alison Conway Fitzgerald, Marie E McDonnell, Sarah C Lassey

AACE Clin Case Rep· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Evidence Shows Clinicians Appropriately Use the Prognostic 40-Gene Expression Profile (40-GEP) Test for High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients.
Perry B Hooper, Aaron S Farberg, Alison L Fitzgerald, Jennifer J Siegel, Briana B Rackley

Cancer Invest· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Making the financial case for immediate postpartum intrauterine device: a budget impact analysis.
Alison C Fitzgerald, Jonathan G Shaw, Kate A Shaw

Am J Obstet Gynecol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Discontinuation, Results Reporting, and Publication of Gynecology Clinical Trials From 2007 to 2020.
Jecca R Steinberg, Christopher J Magnani, Brandon E Turner, Brannon T Weeks, Anna Marie P Young, Alison Conway Fitzgerald

Obstet Gynecol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced metastatic risk assessment in cutaneous squamous cell carcinoma with the 40-gene expression profile test.
Sherrif F Ibrahim, Julia M Kasprzak, Mary A Hall, Alison L Fitzgerald, Jennifer J Siegel

Future Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Utility of the 40-Gene Expression Profile (40-GEP) Test for Improved Patient Management Decisions and Disease-Related Outcomes when Combined with Current Clinicopathological Risk Factors for Cutaneous Squamous Cell Carcinoma (cSCC): Case Series.
Jeremiah H Au, Perry B Hooper, Alison L Fitzgerald, Ally-Khan Somani

Dermatol Ther (Heidelb)· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Methods and Caveats to Risk Factor Assessment in Cutaneous Squamous Cell Carcinoma (cSCC): A Narrative Review.
Aaron S Farberg, Alison L Fitzgerald, Sherrif F Ibrahim, Stan N Tolkachjov, Teo Soleymani

Dermatol Ther (Heidelb)· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analytical validity of DecisionDx-SCC, a gene expression profile test to identify risk of metastasis in cutaneous squamous cell carcinoma (SCC) patients.
Sherri Borman, Jeff Wilkinson, Lauren Meldi-Sholl, Clare Johnson, Kelsey Carter, Alison L Fitzgerald

Diagn Pathol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Effectiveness of Lurasidone in Patients with Schizophrenia: A 12-Week, Open-Label Extension Study.
Masaomi Iyo, Jun Ishigooka, Masatoshi Nakamura, Reiko Sakaguchi, Keisuke Okamoto, Alison Fitzgerald

Neuropsychiatr Dis Treat· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of lurasidone in acutely psychotic patients with schizophrenia: A 6-week, randomized, double-blind, placebo-controlled study.
Masaomi Iyo, Jun Ishigooka, Masatoshi Nakamura, Reiko Sakaguchi, Keisuke Okamoto, Alison Fitzgerald

Psychiatry Clin Neurosci· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of a prognostic 40-gene expression profiling test on clinical management decisions for high-risk cutaneous squamous cell carcinoma.
Graham H Litchman, Alison L Fitzgerald, Sarah J Kurley, Robert W Cook, Darrell S Rigel

Curr Med Res Opin· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sensory acceptable equivalent doses of β-phenylethyl isothiocyanate (PEITC) induce cell cycle arrest and retard the growth of p53 mutated oral cancer in vitro and in vivo.
Aroonwan Lam-Ubol, Alison Lea Fitzgerald, Arnat Ritdej, Tawaree Phonyiam, Hui Zhang

Food Funct· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Down-regulation of malic enzyme 1 and 2: Sensitizing head and neck squamous cell carcinoma cells to therapy-induced senescence.
Sang Hyeok Woo, Liang P Yang, Hui-Ching Chuang, Alison Fitzgerald, Ho-Young Lee

Head Neck· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Wee-1 Kinase Inhibition Sensitizes High-Risk HPV+ HNSCC to Apoptosis Accompanied by Downregulation of MCl-1 and XIAP Antiapoptotic Proteins.
Noriaki Tanaka, Ameeta A Patel, Jiping Wang, Mitchell J Frederick, Nene N Kalu, Alison L Fitzgerald

Clin Cancer Res· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The p53-reactivating small molecule RITA induces senescence in head and neck cancer cells.
Hui-Ching Chuang, Liang Peng Yang, Alison L Fitzgerald, Abdullah Osman, Sang Hyeok Woo

PLoS One· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Wee-1 kinase inhibition overcomes cisplatin resistance associated with high-risk TP53 mutations in head and neck cancer through mitotic arrest followed by senescence.
Abdullah A Osman, Marcus M Monroe, Marcus V Ortega Alves, Ameeta A Patel, Panagiotis Katsonis, Alison L Fitzgerald

Mol Cancer Ther· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of ultrasonic shears and traditional suture ligature for vaginal hysterectomy: randomized controlled trial.
Alison Louise Fitz-Gerald, Jason Tan, Kok-Weng Chan, Alex Polyakov, Geoff N Edwards

J Minim Invasive Gynecol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gain-of-function mutant p53 promotes cell growth and cancer cell metabolism via inhibition of AMPK activation.
Ge Zhou, Jiping Wang, Mei Zhao, Tong-Xin Xie, Noriaki Tanaka, Alison Lea Fitzgerald

Mol Cell· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chk1/2 inhibition overcomes the cisplatin resistance of head and neck cancer cells secondary to the loss of functional p53.
Mayur A Gadhikar, Maria Rita Sciuto, Marcus Vinicius Ortega Alves, Curtis R Pickering, Abdullah A Osman, Alison L Fitzgerald

Mol Cancer Ther· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis